Summary | Jotup

CORRECTION: Previously issued Press Release announcing the case filing did not include the class period as updated below. Pomerantz Law Firm Announces the Filing of a Class Action Against Medical Properties Trust, Inc. and Certain Officers – MPW

Retrieved on:

Tuesday, October 3, 2023

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points:

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
MPW is a self-advised real estate investment trust that was formed to acquire and develop net-leased healthcare facilities.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Medical Properties Trust, Inc. of Class Action Lawsuit and Upcoming Deadline – MPW

Retrieved on:

Tuesday, October 3, 2023

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points:

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
MPW is a self-advised real estate investment trust that was formed to acquire and develop net-leased healthcare facilities.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

MPT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Medical Properties Trust, Inc. and Encourages Investors to Contact the Firm

Retrieved on:

Tuesday, October 3, 2023

Investors have until November 28, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until November 28, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
According to the complaint, on May 23, 2023, MPW issued a press release announcing that it had entered into a recapitalization transaction (the “Recap Transaction”) with Prospect Medical Holdings, Inc. (“Prospect”), a health care management services organization.
On this news, MPW's stock price fell $0.57 per share, or 7.6%, to close at $6.93 per share on August 18, 2023.

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Medical Properties Trust, Inc. (MPW)

Retrieved on:

Monday, October 2, 2023

Class Action Lawsuit, Professional Services, Legal, Medical Properties Trust, LLP, Health, DMHC, Person, Complaint, Prospect, MPW, NYSE, Summary, Security (finance), Inc.

Robbins LLP informs investors that a shareholder filed a class action on behalf of persons or entities who purchased or otherwise acquired Medical Properties Trust, Inc. (NYSE: MPW) securities between May 23, 2023 and August 17, 2023.

Key Points:

Robbins LLP informs investors that a shareholder filed a class action on behalf of persons or entities who purchased or otherwise acquired Medical Properties Trust, Inc. (NYSE: MPW) securities between May 23, 2023 and August 17, 2023.
For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What is this Case About: Medical Properties Trust, Inc. (MPW) Misled Investors Regarding its Recapitalization Transaction with Prospect Medical Holdings, Inc.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Medical Properties Trust, Inc. Shareholders who want to act as lead plaintiff for the class must file their motion for lead plaintiff by November 28, 2023.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Medical Properties Trust, Inc. (MPW)

Retrieved on:

Monday, October 2, 2023

Medicine, Health, Medical Properties Trust, Person, District court, SEC Rule 10b-5, MPW, Complaint, NYSE, Summary

Investors who purchased or otherwise acquired shares of Medical Properties should contact the Firm prior to the November 28, 2023 lead plaintiff motion deadline.

Key Points:

Investors who purchased or otherwise acquired shares of Medical Properties should contact the Firm prior to the November 28, 2023 lead plaintiff motion deadline.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

Class Action Lawsuit Filed on Behalf of Medical Properties Trust, Inc. (MPW) Investors - Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Retrieved on:

Monday, October 2, 2023

Loss, Health, Medical Properties Trust, MPW, Fraud, NYSE, Summary, ISS, Property management

ATLANTA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Medical Properties Trust, Inc. (“MPW” or the “Company”) (NYSE: MPW).

Key Points:

ATLANTA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Medical Properties Trust, Inc. (“MPW” or the “Company”) (NYSE: MPW).
at [email protected] , by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at https://holzerlaw.com/case/mpw/ to learn more.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation.
Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

Cerebrum Tech's latest endeavor Cere Insight, an AI chatbot that speeds up work and shortens work hours

Retrieved on:

Tuesday, September 19, 2023

Workforce, Marketing, LLM, Culture, Internet of things, ChatGPT, Intelligence, Research, Lawyer, Summary, App Store (iOS/iPadOS), Student, Commerce, AI, Retail, Industrial design, Customer service

ISTANBUL, Sept. 19, 2023 /PRNewswire/ -- Cerebrum Tech 's latest endeavor, Cere Insight, is set to redefine the landscape of artificial intelligence tools, promising to simplify and enhance the modern work environment.

Key Points:

ISTANBUL, Sept. 19, 2023 /PRNewswire/ -- Cerebrum Tech 's latest endeavor, Cere Insight, is set to redefine the landscape of artificial intelligence tools, promising to simplify and enhance the modern work environment.
In a world where efficiency and innovation are paramount, Cere Insight emerges as a powerful solution, ushering in a new era of accessible artificial intelligence.
Leading this relentless pursuit of innovation, Cerebrum Tech is an entrepreneurial powerhouse specializing in cutting-edge technologies including AI, IoT, and game development.
Established in 2021, Türkiye, Cerebrum Tech harnesses the transformative power of AI, IoT, and Web3 to maximize productivity through accessible, user-friendly, and secure products.

Cerebrum Tech's latest endeavor Cere Insight, an AI chatbot that speeds up work and shortens work hours

Retrieved on:

Tuesday, September 19, 2023

Workforce, Marketing, LLM, Culture, Internet of things, ChatGPT, Intelligence, Research, Lawyer, Summary, App Store (iOS/iPadOS), Student, Commerce, AI, Retail, Industrial design, Customer service

ISTANBUL, Sept. 19, 2023 /PRNewswire/ -- Cerebrum Tech 's latest endeavor, Cere Insight, is set to redefine the landscape of artificial intelligence tools, promising to simplify and enhance the modern work environment.

Key Points:

ISTANBUL, Sept. 19, 2023 /PRNewswire/ -- Cerebrum Tech 's latest endeavor, Cere Insight, is set to redefine the landscape of artificial intelligence tools, promising to simplify and enhance the modern work environment.
In a world where efficiency and innovation are paramount, Cere Insight emerges as a powerful solution, ushering in a new era of accessible artificial intelligence.
Leading this relentless pursuit of innovation, Cerebrum Tech is an entrepreneurial powerhouse specializing in cutting-edge technologies including AI, IoT, and game development.
Established in 2021, Türkiye, Cerebrum Tech harnesses the transformative power of AI, IoT, and Web3 to maximize productivity through accessible, user-friendly, and secure products.

Climb Global Solutions Reports Second Quarter 2023 Results

Retrieved on:

Wednesday, August 2, 2023

Natural borrowing limit, SG, GAAP, ERP, Public expenditure, EBITDA, Acquisition, Investment, Elevate, Growth, Summary, Video game, Bank, Pharmaceutical industry

EATONTOWN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, is reporting results for the second quarter ended June 30, 2023.

Key Points:

EATONTOWN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, is reporting results for the second quarter ended June 30, 2023.
Net sales in the second quarter of 2023 increased 20% to $81.7 million compared to $67.9 million for the same period in 2022.
Gross profit in the second quarter of 2023 increased 10% to $13.7 million compared to $12.5 million for the same period in 2022.
The Company will conduct a conference call tomorrow, August 3, 2023, at 8:30 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2023.

Canadian VC funding recovers to $1.95B in Q2, reports $3.25B for first half of 2023

Retrieved on:

Friday, July 28, 2023

TORONTO, July 28, 2023 /CNW/ - Canadian venture capital (VC) recovered from its recent low of $1.3 billion in Q1, 20231 to report $1.95 billion in Q2 2023 in disbursements2.

Key Points:

TORONTO, July 28, 2023 /CNW/ - Canadian venture capital (VC) recovered from its recent low of $1.3 billion in Q1, 20231 to report $1.95 billion in Q2 2023 in disbursements2.
For the first half of 2023, Canadian VC disbursements reached $3.25 billion, almost at par with that of Q1 2022, representing 62% decreases from the same period in 2022.
International investors from 28 countries or regions invested $512 million, accounting for 16% of total funding in H1 2023.
We cover all aspects of VC information, not limited to but including Canada's only information on VC firm fundraising, VC funding sources (where all the VC came from).